Unt i l 10 years ago, cardiac catheterization was predominantly a diagnostic tool for defining anatomic and functional disease states before cardiac surgical correction. After a decade of tentative exploration with the fixed rigid dilator technique of Dotter, balloon dilatation was developed by Andreas Gruentig in 1974 as a treatment for peripheral atherosclerotic stenosis, ushering in the new field of cardiology. The current supplement to the American Journal of Cardiology is based on a symposium that was sponsored by Advanced Cardiovascular Systems in June 1987 to assess the status of this important new field in which the cardiac catheter is used to render definitive treatment of cardiovascular disease, as well as to provide diagnostic data. The centerpiece of interventional cardiology today is percutaneous transluminal coronary angioplasty (PTCA). During the early years of PTCA (1977 through 1981), relatively crude devices and inexperienced operators limited PTCA to patients with proximal, discrete, subtotal stenosis of a single coronary artery (who comprised only 5 to 10% of the population requiring coronary revascularization), and to a primary success rate of only 60%. In contrast, coronary angioplasty is now being applied routinely to patients with more complex coronary anatomic situations, including distal disease, stenosis of multiple vessels, bifurcation lesions, total occlusions, and diseased saphenous vein or internal mammary artery bypass grafts. Concomitant with this expansion in the anatomic capabilities of coronary angioplasty has been a marked broadening of its clinical indications, which now include patients with chronic stable angina, unstable angina, acute myocardial infarction, clinical features that make bypass surgery unacceptable, and a small subgroup of
Read full abstract